Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Can virtual reality tools help teach obstetrics and gynecology topics to medical students?

Written by | 9 Mar 2023

Results from a trial published in the International Journal of Gynecology & Obstetrics support the benefit of 3D virtual reality lessons to improve medical students’ knowledge and understanding of complex… read more.

Antibiotics after birth affects gut microbes of babies

Written by | 22 Feb 2022

Treating babies with antibiotics in the first week of life is linked with a decrease in healthy bacteria necessary amongst others to digest milk and an increase in… read more.

High blood pressure treatment in pregnancy appears safe, prevents maternal heart risks

Written by | 22 Dec 2021

Treatment for high blood pressure during pregnancy appears safe for many women and may reduce maternal risk for severe hypertension without increasing fetal and neonatal risks, according to… read more.

Planned home birth presents little risk where midwifery is well-integrated

Written by | 14 Oct 2021

In the state of Washington, a planned home birth with a licensed midwife is just as safe as a birth at a licensed birth centre. Researchers from the… read more.

FDA approves Solosec for trichomoniasis in adults – Lupin Pharma

Written by | 10 Jul 2021

Lupin Pharmaceuticals announced that the FDA has approved the company’s supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis… read more.

Scynexis announces FDA approval of Brexafemme as the first and only oral non-azole treatment for vaginal yeast infections

Written by | 6 Jun 2021

Scynexis Inc.,. announced that the FDA has approved Brexafemme(ibrexafungerp tablets), for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. Brexafemme which represents… read more.

Better choice of contraceptives can prevent breast cancer

Written by | 5 Jun 2021

An EPFL study into the distinct biological effects of different progestins on the breast shows that contraceptive-related breast cancer can be prevented by more informed choices about the… read more.

Bacteria do not colonize the gut before birth

Written by | 18 May 2021

New research led by scientists from McMaster University and Charité — Universitätsmedizin Berlin in Germany has found it happens during and after birth, and not before. McMaster researchers… read more.

Pregnant women with COVID-19 face high mortality rate

Written by | 1 May 2021

In a worldwide study of 2,100 pregnant women, those who contracted COVID-19 during pregnancy were 20 times more likely to die than those who did not contract the… read more.

Worm infestation in intestine has a remote effect on viral defenses

Written by | 22 Apr 2021

Infection with parasitic intestinal worms (helminths) can apparently cause sexually transmitted viral infections to be much more severe elsewhere in the body.

Gut microbiota in cesarean-born babies catches up

Written by | 3 Apr 2021

Infants born by cesarean section have a relatively meager array of bacteria in the gut. But by the age of three to five years they are broadly in… read more.

Lupin will partner with Endoceutics to commercialise Intrarosa for postmenopausal vulvovaginal atrophy in Canada

Written by | 20 Mar 2021

Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.